Defence Therapeutics Inc (DTC.CX)
0.39
0.00 (0.00%)
CAD |
CNSX |
Oct 23, 16:00
Defence Therapeutics Net Income (Quarterly) : -2.962M for March 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -2.962M |
| December 31, 2025 | -1.522M |
| September 30, 2025 | -0.703M |
| June 30, 2025 | -1.158M |
| March 31, 2025 | -0.9519M |
| December 31, 2024 | -0.8048M |
| September 30, 2024 | -0.6069M |
| June 30, 2024 | -1.348M |
| March 31, 2024 | -1.328M |
| December 31, 2023 | -8.320M |
| September 30, 2023 | -2.197M |
| June 30, 2023 | -1.729M |
| March 31, 2023 | -1.343M |
| December 31, 2022 | -1.988M |
| Date | Value |
|---|---|
| September 30, 2022 | -1.703M |
| June 30, 2022 | -2.178M |
| March 31, 2022 | -1.695M |
| December 31, 2021 | -1.941M |
| September 30, 2021 | -1.53M |
| June 30, 2021 | -1.685M |
| March 31, 2021 | -0.6907M |
| December 31, 2020 | -0.4423M |
| September 30, 2020 | -0.0415M |
| June 30, 2020 | -0.4715M |
| March 31, 2020 | -0.1923M |
| December 31, 2019 | -0.0029M |
| September 30, 2019 | -0.0065M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Spectral Medical, Inc. | 0.331M |
| Resverlogix Corp. | -8.421M |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | -0.2796M |
| Restart Life Sciences Corp. | -1.017M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.962M |
| EPS Diluted (Quarterly) | -0.0502 |
| Enterprise Value | 28.09M |
| Earnings Yield | -28.64% |
| Normalized Earnings Yield | -23.85 |